Alpha Teknova (TKNO) Short term Debt (2023 - 2024)

Alpha Teknova (TKNO) posted quarterly Short term Debt of $4.0 million for Q4 2024, up 60.01% quarter-over-quarter from $2.5 million in Q3 2024.

Alpha Teknova (TKNO) Short term Debt (2023 - 2024) Analysis & Trends

Alpha Teknova (TKNO) has reported Short term Debt for 2 consecutive years, with $4.0 million the latest figure, recorded in Q4 2024.

In Q4 2024, Short term Debt changed N/A year-over-year to $4.0 million; the TTM figure through Dec 2024 stood at $4.0 million (changed N/A YoY), while the FY2024 annual figure was $4.0 million, changed N/A from the prior year.
Short term Debt climbed to $4.0 million in Q4 2024 per TKNO's latest filing, from $2.5 million in the prior quarter.
Across five years, Short term Debt topped out at $22.2 million in Q2 2023 and bottomed at $1.0 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-
10	Alpha Teknova	374.37 Mn	356.94 Mn	4.89 Mn

Download Data